Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...
Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a well-known cancer-related protein called ezrin. This finding could potentially open ...
When a patient is diagnosed with osteosarcoma, an aggressive form of bone cancer, the mission is to remove the tumor entirely. Leaving behind even a microscopic cluster of malignant cells can be the ...
Sudden, unexplained bone breaks could be a sign of cancer. Even though most low-trauma fractures come from osteoporosis or falls, certain cancers can weaken bones. Doctor stresses that fractures out ...
While bone cancer is relatively rare – about 0.4% of all cancer deaths and 0.2% of all new cancer cases in the US in 2025 – it’s devastating, causing difficulty in moving limbs, bone fractures, and ...
A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the precision and comfort of cancer therapy. Designed by a team of researchers ...
Chondroblastoma is a rare, benign bone tumour that most commonly arises in the epiphysis or apophysis of long bones, particularly affecting adolescents and young adults, though cases in older patients ...
Bionano Genomics, Inc. announced a groundbreaking study published in Modern Pathology, which highlights the effectiveness of optical genome mapping (OGM) in detecting bone and soft tissue tumors. This ...
Douglas teen dies after two-year battle with bone cancer; family seeks community support for funeral expenses ...
Add Yahoo as a preferred source to see more of our stories on Google. Preparing for a medical test often triggers health anxiety, making it easy to worry about hidden conditions and care needs. While ...
Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India Diagnostic concordance was observed in 296 cases ...